Endocrine Flashcards

1
Q

Glicozide action

A

binds to ATP dependent pottasium channel on membranes of pancreatic beta cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

hypokaleamia with high BP

A

Cushing’s
Conn’s
Liddle’s
11-beta hydoxylase def

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

hypokaleamia without hypertension

A

Dieuretics
GI loss
Renal tubular acidosis
Barttres
Gitelmans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Bartters syndrome

A

defect in NKCC2 channel defect in ascending limb of loop of Henle
failure to thrive
salt wasting
metabolic alkalosis
urinary calcium elevated
polyhdramniosis
high bicarb - compromised cl reabsorption interfere withcl/bi carb exchange
increased renin, aldesterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Gitlman’s syndrome

A

defect in in NaCl transporter in DCT
less severe than Bartters
metabolic alcolosis,** low urinary calcium,** hypocaleasema,, low magnesium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

latent Autoimmune Diabetes of Adulthood

A
  • Presence of islet antibodies of slow progression
  • Clinical features: Adult-onset diabetes, + Type 1 diabetes-associated autoantibodies (such as GAD65, IA-2, and ZnT8)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

3 criteria for the diagnosis of LADA

A
  1. Age greater than 30 years
  2. Positive autoantibodies to islet β cells
  3. Insulin independence for at least the initial 6 months after initial diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Maturity-onset diabetes of the young (MODY)

A

Early onset (before age 30), autosomal dominant inheritance, and impaired insulin production
asymptomatic and young slim individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Maturity-onset diabetes of the young (MODY)

A
  1. HNF1A 30% to 60% of MODY.
  2. HNF4A 5% to 10% of MODY
  3. GCK 30% to 60% of MODY.
  4. HNF1B less than 5% of MODY.

lack of islet autoantibodies - characteristic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MODY Genes Associated Syndromes

A
  1. Wolfram Syndrome/ DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness)
  2. Thiamine-responsive megaloblastic anemia syndrome
  3. Maternity-inherited diabetes with deafness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SGLT 2 inhibitors action

A

Reversibly Inhibit SGLT 2 in PCT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SGLT 2 inhibitors adverse effects

A
  1. increase urine output
  2. weight loss
  3. UTI & genital infections
  4. Normoglycemic ketoacidosis
  5. lower limb aputation risk
  6. Founeirs Gangrene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Adverse effects of sulphanurea

A

hypoglycemic epicodes
hyponatremia
bone marrow suppression
pheriperal nuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Type 1 RTA associations

A

Distal convuluting Tubules
- Low K+
- hight Ca
- PH>5.5
- renal calculai
- Associatd with SS & RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Kallmann syndrome traid

A
  1. Delayed or absent puberty,
  2. Anosmia or hyposmia
  3. Infertility

deficiency in gonadotropin-releasing hormone (GnRH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lupus pernio (Besnier-Tenneson syndrome)

A
  • Blue red to violet smooth shiny nodules and plaques on the head and neck, predominantly on the nose, ears, lips, and cheeks
  • Pathognomonic of sarcoidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Systemic glucocorticoid achne features

A

monomorphic papular rash without comedons or cysts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cervical cancer risk factors

A

HIPS C
HPV types 16, 18, and 31; high risk exposure
Immunocompromised individuals: long term steroids, HIV, transplant patients
Promiscuity: multiple partners
Smoking
COCP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  1. features of addison’s disease
    2.
A

high K+
low Na+
low sugar
loss of pubic hair, nor bolding
2. adrenocorticotrophic hormone stimulation (Synacthen®) test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hashimoto’s thyroiditis associated cancers

A

thyroid MALT lymphoma
(Extranodal marginal zone B-cell lymphoma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

The Rotterdam criteria

A

2 ot of 3 of the followings
- oligo- or anovulation,
- hyperandrogenism (clinical or biochemical)
- polycystic ovarian morphology (PCOM) on ultrasound.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

thyrotoxic storm treatment in the background of DKA

A

Betablockers
PTU
hydrocortisol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

hashimoto’s thyroiditis

A

hypothyroidism
Goiter
Anti TPO, anti thiroglobulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Liddle’s syndrome

A

Hypertension
Hypokalemia
Metabolic Alkalosis
Autosomal dominant
epithelial sodium channel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Primary Hyperparathyroidism

A

common - parathyroid adenoma,
PTH high / normal
Ca High

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Causes Causes of SIADH

A

SIADH Cannot Void
S: SSRIs (Sertaline)
I: Indomethacin (Analgesics)
A: Antidepressants (Tricyclics)
D: Diuretics (Thiazides)
H: Haloperidol
Cannot: Cyclophosphamide, Carbamazepine
Void: Vincristine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Lithium Diabetic Incepides

A

ibcrease urine outout
low urine osmolality
raised plasma osmolality
hypernatremia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

SIADH

A

low urine output
low sodium
Low plasma osmolality
High urine osmolality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Addisons diesese and cortisol level

A
  • <100 = Addisons or hypoadresalism likely
  • 100<Cortisol < 500 = inconclusive - Short Synacthon test
  • > 500 = Addisons unlikely
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

electrolyte abnormalities in Addisons

A

Hypercalemia
hyponatremia
hypoglicemia
metabolic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Metabolic syndrome

A

central obesity
insulin resistance
hypertension, and dyslipidemia
poses a significant risk for the development of atherosclerotic cardiovascular diseases
type II diabetes mellitus

other conditions - raised Uric acid levels, Polysisctic ovarian syndrome, fatty liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Diagnosis of DKA

A

Glucose >11
pH<7.3
Bicarbonate <15
Blood ketones >3 or urine ketones 2+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Urge incontinence 1st line for elderly

A

Mirabegron - Mirabegron is a selective beta-3 adrenergic receptor agonist.
oxybutinin can cause confusion in elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Multiple Endocrine Neoplasia type 2B (MEN2B)

A

Marfanoid habitus, edullary thyroid cancer, pheochromocytoma, and mucosal neuromas
RET proto onco gene present

35
Q

MEN type 1

A

3 P’s
Parathyroid gland
Pancreas
Pituitary gland

36
Q

MEN type 2A

A

medullary thyroid cancer >70%
2Ps
Pheochromocytoma - Adrenal
Parathyroid
RET proto onco gene present

38
Q

Acromigaly Management

A

1st line - Transphenoidal surgery
if unsuccessfull medications
1. somatosatin analogue
2. pegvisoman
3. dopamine agonists

colorectal cancer risk increased

39
Q

Actopic ACTH

A
  • same clinical presentation as Cushings, but with severe hypokalemia and very high ACTH
  • doesnt respond to high dose dexa suppression
40
Q

Cushings disease

A

8- cushings syndrome + elevated 9 am cortisol and high ACTH
- respond to high dose Dexa (2mg 6hr for 48hr)
-dexa respond to pituirary only, CRH - increasse cortisol (0nly in piturory )

41
Q

Primary hyperparathyroidism

A

80% Solitory Adenoma
10% Hyperplasia
1% cancer
80% symptomatic
- polydipsia, polyurea, depression, constipation, peptic ulcers, pancreatitis, bone pain fractures, kidney stones, hypertension
- high Ca+, low Ph+, PTH could be normal
- Scan - Techniciam Mibi substraction
- X ray - paper pot skull, ostiitis, fibrosa cystica
- Management - parathiroidectomy, non - surgical = cinacalcet

42
Q

Complications of pregnancy related to thirotoxicosis

A

Fetal loss
maternal heart failure
premature labor

43
Q

If triple therapy with metformin and 2 other oral drugs (gliplazin + Sulphunilurea) failed (BMI >35)

A

Replace GLP-1 mimetic instead of gliclazide

44
Q

GLP-1 side effects

A
  • Ketoacidosis
  • Severe gastro-intestinal disease (not
    for liraglutide and semaglutide)
  • Liraglutide: diabetic gastroparesis,
    inflammatory bowel disease
45
Q

DPP-4
inhibitor
(‘gliptins’)

A

Ketoacidosis
No Hypoglycaemia
risk

46
Q

Acromegaly Diagnosis

A

IGF 1 level followed by OGTT + serial GH measurements

47
Q

hypoglycemia due to insulin
1. Symptoms
2. Hormonal response

A
    • Shakiness, sweating, dizziness, or lightheadedness.
      - Hunger, confusion, or difficulty concentrating.
      - Rapid heartbeat, blurred vision, or headache.
      - In severe cases, seizures, loss of consciousness, or coma
  1. Glucagan increase
    - adrenalin, cortisol increase
48
Q

Schematic representation of glucose metabolism

A

1: Hexokinase/glucokinase,
2: Glycogen synthase,
3: Phosphorylase,
4: Phosphofructokinase,
5: Pyruvate kinase,
6: Pyruvate carboxylase,
7: Phosphoenolpyruvate carboxykinase,
8: Fructose-1,6-biphosphatase,
9: Glucose-6-phosphatase.

49
Q

Thyroid bining globilin in pregnancy

A

eastrogen - Liver TBG increases
and bind to FT3 & FT4
rerduce free T3, T4
Secondary Increase increase in TSH

50
Q

klinefelter syndrome

A

Male phenotype, Karyotype (47, XXY),
Long/tall,
Infertile, gyenicomastia
Nondisjunction,
Eunuchoid body proportions,
FSH elevated, High LH (Elevated Gonadotropins)
Minimal facial & axillary hair,
Estradiol/testosterone ratio elevation

51
Q

Hyperthyroidism clinical manifestations

A

Pretibial Myxedema (Thyroid Dermopathy)
Hyperpigmentation
Vitiligo

52
Q

Galactosemia

A

Diagnosis - Neontal screening - elevated levels of galactose-1-phosphate
Classic Galactosemia: Mutation in enzyme galactose-1-phosphate uridyltransferase (GALT).
Variant Galactosemia: GALK1 and GALE.
clinical manifestations - oor feeding, jaundice, liver damage, and cataracts, Sepsis
if not treated - failure to thrive and interlectual difficulties

53
Q

Pioglitazone
1. mech action
2. contraindications

A
  1. The thiazolidinedione, reduces peripheral insulin resistance, leading to a reduction of blood-glucose concentration. PPAR Gamma
  2. History of heart failure, previous or
    active bladder cancer, uninvestigated
    macroscopic haematuria, causes weight gain, liver imparement
54
Q

carbimazole mechanism of action

A

Blocks thyroid hormonogenesis by inhibiting the action of thyroid peroxidase, organification of iodide and their uptake by tyrosyl radicals as well as the coupling of iodotyrosines with iodothyronine residues (T3 and T4) which in turn suppress the synthesis of thyroid hormones

55
Q

Causes of drug induced hyponatraemia

A

Anticancer agents - Vinca alkaloids (e.g. Vincristine), platinum compounds (e.g. Cisplatin), Alkylating
agents (e.g. Cyclophosphamide)
Anti-depressants - Tricyclic antidepressants, SSRIs, MAOI
Anti-epileptic medications - Carbamazepine, Sodium Valproate
Anti-hypertensives - ACEi, ARB, Amlodipine
Anti-pyschotic medications - henothiazines, Butyrophenones
Diuretics - Thiazides, Indapamide, Amiloride, loop
diuretics
Proton pump inhibitors - Omeprazole

56
Q

Cause of hyponatraemia

A
  1. Medications (most commonly thiazide diuretics).
  2. Syndrome of inappropriate antidiuresis.
  3. Underlying medical conditions (such as heart failure, kidney disease, and liver disease).
57
Q

The severity of hyponatraemia can be classified as:

A

Mild — serum sodium concentration 130–135 mmol/L.
Moderate — serum sodium concentration 125–129 mmol/L.
Severe — serum sodium concentration less than 125/120 mmol/L.

58
Q

Pseudo-hyponatraemia

A

false low serum Na+ concentration due to hyperproteinaemia - multiple myeloma or hypertriglyceridaemia

59
Q

Hypertonic (or hyperosmolar) hyponatraemia

A
  • Severe hyperglycaemia (the high levels of glucose draw intracellular water into the extracellular space)
  • Administration of an active osmolyte (such as mannitol)
60
Q

Hypovolemic (volume depletion) hyponatraemia causes

A
  • Medications, especially thiazide diuretics.
  • Endocrine disorders (primary adrenal insufficiency).
  • Cerebral salt-wasting (a rare cause of hyponatraemia resulting from a central nervous system insult such as aneurysmal subarachnoid haemorrhage).
  • Severe diarrhoea and/or vomiting (gastrointestinal sodium loss).
  • Sweating (for example during exercise) and extensive skin burns (transdermal sodium loss).
  • Salt-wasting nephropathies, for example tubulopathy after chemotherapy.
  • Third space losses — bowel obstruction, pancreatitis, severe hypoalbuminaemia, sepsis, or muscle trauma
61
Q

Hypervolemic (volume overload) hyponatraemia causes

A
  • Congestive heart failure.
  • Liver disease (cirrhosis with ascites).
  • Kidney disease (acute kidney injury, chronic kidney disease, nephrotic syndrome).
62
Q

Euvolemic (normal volume status) hyponatraemia

A
  • Drugs (for example selective serotonin-reuptake inhibitors and thiazide diuretics).
  • Syndrome of inappropriate antidiuretic hormone secretion (SIADH).
  • Endocrine disorders (secondary adrenal insufficiency and hypothyroidism [very rare cause]).
  • High water low solute intake — primary polydipsia, anorexia nervosa, and beer potomania (excess beer consumption with a low solute diet).
63
Q

Gestational diabetic criteria

A

OGTT test
fasting >5.6
2 Hour >7.8

64
Q

Gestational Diabetic management

A

Metformin (fasting Glucose <7, not controlled by diet/ fasting)
Insulin (if not treated with insulin)
Treated with short acting (no long acting)

65
Q

Gestational Diabetic complications

A

Macrosmia
polyhydro amnio

66
Q

Hypocalcemia, ECG

A

QT Interval Prolongation:
rare : Peaked T waves, Torsades de pointes, Atrial Fib

67
Q

Anaplastic thyroid cancer (ATC)

A

Rare, aggressive, spreads rapidly, often leading to a poor prognosis
>60 years

68
Q

Papillary thyroid carcinoma

A
  • Slow-growing, palpable lump, Asymptomatic
  • Risk Factors: Radiation Exposure, Genetic Factors, Family History
  • young females
  • ## treatable
69
Q

Familial hypercholesterolemia

A
  • autosomal dominant
  • high LDL

**Simon Broome Criteria **
1. adult - total chol- 7.5, LDL- 4.9
Child- total - 6.7, LDL - 4
2. tendon xanthoma,
3. Family histiory

tretatment - high dose statin

70
Q

Gynecomastia causing drugs

71
Q

Renal artery Stenosis vs primary hyperaldesteronism

A

PH - high Bp, Low K+, high Na+, low Renin (diagnosed from treatment resistent hypertension with low K+), aldesterone renin ratio high
RTS - kow k+, high Aldesterone, High Na+, High Renin

72
Q

secondary hyperparathioridism

A

in renal failure, low vit D, low Ca, raised PTH, raised ALP due to bone resoption

73
Q

tertiry Hyperparathiroidism

A

long standing secodnary hyperpara result in hyperplasia of parathiroid gland.
raised Ca, raised PTH, high Ph

74
Q

Thyroid eye disease (TED)

A

changes in color vision - urgent decompression surgery

75
Q

insulinoma

A

pancreatic tumors that produce excess insulin
lead to hypoglycemina
diagnosis- supervised fasting (72 hrs)
nuroendocrine tumor in pancreartic beta cells in langhanns
MEN 1 associated

primary treatment for insulinoma is surgical removal of the tumor.

hypoglycemia, including sweating, tremors, palpitations, confusion, and in severe cases, seizures or loss of consciousness

A diagnosis of insulinoma is often suspected when a patient presents with Whipple’s triad, which includes:
Symptoms of hypoglycemia
Documented low blood sugar (glucose) at the time of symptoms
Improvement of symptoms after glucose administration

76
Q

Prolactinoma
causes of raised prolactin

A

pregnancy
prolactinoma’
PCOS
primary hyporthiroidism
metacropanide
domperidone
phenothiozene

77
Q

features of excess prolactin

A

men - loss of libido, impotence,galactoria
female- amenohria, galactoria

78
Q

clomofin action

A

Anti eastrogen

79
Q

heavy smokers with high BP and altered mental status, polyurea, weight gain

A

metabolic alcolosis with hypocalemia
small cell lung cancer - Ectopic ACTH

80
Q

Complete Andregen Insensitvity Syndrome

A

XY along with inability of body cells to responds to andregens, rudimentory testes
Bi lateral groin swelling

81
Q

Diabetic neuropathy

A

amitriptiline, deuloxitine, gaba pentin

82
Q

poorly controlled diabetic normal vision, funduscopy neovascularization

A

risk of vitriuos haemorrage
treatment- lasor photocoagulation

83
Q

pitutory adenoma

A

secretory - prolactinoma
nonsecretory -